Recent Cervical Cancer News

FDA Approves Merck’s Keytruda® for Previously Treated Patients with Recurrent or Metastatic Cervical Cancer Whose Tumors Express PD-L1

(June 18, 2018)

The U.S. Food and Drug Administration (FDA) has approved Keytruda (pembrolizumab) for the treatment of patients with recurrent or metastatic cervical cancer with disease progression on or after chemotherapy... Continue Reading


Questions to Ask Before Radiation Therapy for the Treatment of Cervical Cancer

(December 13, 2017)

Radiation therapy, or radiotherapy, is a common way to treat cervical cancer. Doctors who specialize in treating cancers with radiation are known as radiation oncologists. During radiation therapy, high-energy... Continue Reading


Managment of the Side Effects of Radiation for Cervical Cancer

(December 7, 2017)

Radiation therapy, or radiotherapy, is a common way to treat cervical cancer. With any treatment of cancer you must first understand your responsibility and your medical team’s role as well as explore... Continue Reading


What You Should Know About the Side Effects of Surgery for Cervical Cancer

(December 6, 2017)

A hysterectomy is a common surgical treatment of early stage cancer and precancerous disease of the cervix in women. With any treatment of cancer it is important to first understand your responsibility... Continue Reading